The medical world is seeing a significant shift in blood sugar therapy with the introduction of GLP-1 skin applications. These devices offer a possibly more user-friendly alternative to shots of GLP-1 receptor agonists, lessening the requirement of daily needle pricks. The innovation delivers the medication directly through the surface, potentially